论文信息 - Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin. - 字舞流文

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.

E. Giovannetti | G. Peters | C. Tibaldi | E. Smit | F. di Costanzo | A. Ardizzoni | M. Tiseo | J. Burgers | A. Vincent | F. Barbieri | A. Camerini